TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
INO

Inovio Pharmaceuticals Inc

Healthcare · Biotechnology

1.30$ -3.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Inovio Pharmaceuticals Inc (INO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 49 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
193 171 129 134 107 113 87 68 69 74 50 49
175 153 112 118 91 98 72 53 55 61 39 40
19 14 20 34 22 66 40 24 37 44 26 32
167 145 106 110 85 94 68 48 51 59 38 37
2.1 2.4 2.6 1.8 1.9 1.2 1.3 0.8 1.0 0.0 – –
– – – – 86,576 – – – – – – –
15 – – – – – – – – – – –
0.0 0.0 – – – – – – – – – –
55 54 35 37 34 45 36 40 77 50 44 45
44 43 23 26 23 35 27 32 70 44 38 40
19 19 2.2 2.3 2.4 2.5 2.6 2.7 2.7 2.8 2.9 2.9
3.9 4.6 8.3 6.4 5.4 6.4 5.5 5.5 5.9 2.6 2.0 12
138 117 94 97 74 69 51 29 -7.7 24 6.1 4.4
-1,598 -1,623 -1,653 -1,686 -1,711 -1,730 -1,750 -1,773 -1,819 -1,815 -1,835 -1,841
22 23 23 27 28 27 27 39 52 69 69 82

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?